Clover Biopharmaceuticals Doses First Patient in Phase I Study of SCB-313 in China for Malignant Ascites Read more
Kinoxis Therapeutics Awarded NIH HEAL Initiative Grant to Advance KNX100 for the Treatment of Opioid Withdrawal Read more
Exclusive Bionical EMAS speaker interview released for the Orphan Drugs & Rare Diseases Conference Read more
An exclusive speaker interview with twoXAR CEO for SMi’s 3rd Annual Ophthalmic Drugs Conference 2019 Read more
European Commission Grants Orphan Drug Designation for Nirogacestat for the Treatment of Soft Tissue Sarcoma Read more
Blade Therapeutics Expands Anti-Fibrotic Pipeline With Acquisition of ATXCo and Its Autotaxin Inhibitor (PAT-409) Read more